Cancer stem cells are cancer cells (found in tumours or haematological malignancies) that have features similar to normal stem cells, such as the ability to produce all cell types observed in a cancer sample. In contrast to other non-tumorigenic cancer cells, CSCs are tumorigenic (may cause tumours).
The field of stem cell research is filled with possibilities for medical advancement. Researchers are exploring the use of embryonic or induced pluripotent stem cells in the development of medicines and disease models. They also look at fundamental concepts like stem-cell pluripotency and self-renewal, as well as stem cells in the context of both normal and malignant development.
Cancer stem cell markers
Cancer stem cell transcription factors
Epithelial to Mesenchymal Transition
Induced Pluripotent stem cells
Malignant Development
Related: Clinical Oncology Webinar | Cancer Pharmacology Webinar 2021 | Oncology Conference 2021 | Clinical Oncology Conference | Oncology Conference Virtual Meeting | Oncology Conference Online | Clinical Oncology and Pharmacology Meeting | Webinar on Clinical Oncology and Pharmacology | Conference on Oncology | Virtual Meeting on Clinical Oncology and Pharmacology | Cancer virtual conference 2021 | Oncology Online meeting |
Related Societies: American Society of Clinical Oncology | Community Oncology Alliance | Society of Surgical Oncology | American Society of Therapeutic Radiology and Oncology | American Association of Cancer Research | American Cancer Society | National Cancer Institute | National Comprehensive Cancer Network |
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
